04.06.2012

Innovative Core Biotechnology

Berlin-Brandenburg is one of the leading life science locations in Germany. Here is where the strongholds of medicine, scientific research, and training are at home. The key drive behind all this innovation is the biotechnology sector, which has been enjoying continuous growth since the mid-nineties. This sector starts out from a large number of “omics” technologies, e.g. genomics, proteomics, metabolomics, epigenomics, and their interlinks forged by bioinformatics and systems biology.

Berlin-Brandenburg institutions and their scientists are pioneers in these fields and are shaping the research landscape throughout the world. This rich soil has since been nurturing over a hundred biotechnology companies. This innovative core of biotechnology is also instrumental in attracting a growing number of pharmaceutical companies to Berlin and boosting growth on the medical engineering sector here. After all, new developments in medicine today are virtually no longer possible without biotechnology, and many innovations of medical engineering are based on biologi-cal coatings. 

While biotechnology has been pervading nearly all segments of everyday life in recent years, the sector itself is experiencing its ups and downs. In the face of ailing financial markets and a dramatic upheaval in the pharmaceutical and health care industry, the business model for developing new medicines has become very difficult. On the other hand, companies will evolve at an above average rate, combine biotechnologies with other disciplines, and so tap into new markets. We expect booming growth at the interfaces between biotechnology and medical engineering, imaging and molecular diagnostics, diagnostics and pharmaceuticals, health and IT, and a large number of new products and methods.

And it is Adlershof that provides excellent potential for interdisciplinary products. Adlershof is the treasure trove of varied and diverse expertise in automation, high throughput methods, optical technologies, microsystems engineering, and in physical, chemical, and biological mechanisms.

Dr Kai Bindseil,
Cluster Manager Health Capital BioTOP Berlin-Brandenburg